Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
AMRX has 2 Form 4 insider filings recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001723128 (2026-04-11) ↗